No Evidence of Off-label Use of Olodaterol and Indacaterol in Denmark, France, and the Netherlands:A Drug Utilization Study

To characterize the use of olodaterol and indacaterol in clinical practice and to quantify the off-label use in asthma. Drug utilization study of new users of olodaterol or indacaterol between 2014 and 2017 in the PHARMO Database Network in the Netherlands, the Danish population registers, and the IMS Real-World Evidence Longitudinal Patient Database panels in France. On-label use was defined as use among adults with a recorded diagnosis of COPD. Off-label use was defined as use among adults with a recorded diagnosis of asthma without a recorded diagnosis of COPD or as use among patients aged... Mehr ...

Verfasser: Rebordosa, Cristina
Houben, Eline
Laugesen, Kristina
Bothner, Ulrich
Montonen, Jukka
Aguado, Jaume
Overbeek, Jetty A.
Ehrenstein, Vera
Asmar, Joelle
Wallace, Laura
Gilsenan, Alicia W.
Dokumenttyp: Artikel
Erscheinungsdatum: 2020
Reihe/Periodikum: Rebordosa , C , Houben , E , Laugesen , K , Bothner , U , Montonen , J , Aguado , J , Overbeek , J A , Ehrenstein , V , Asmar , J , Wallace , L & Gilsenan , A W 2020 , ' No Evidence of Off-label Use of Olodaterol and Indacaterol in Denmark, France, and the Netherlands : A Drug Utilization Study ' , Scientific Reports , vol. 10 , no. 1 , 586 . https://doi.org/10.1038/s41598-019-57397-5
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27599620
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://pure.au.dk/portal/da/publications/no-evidence-of-offlabel-use-of-olodaterol-and-indacaterol-in-denmark-france-and-the-netherlands(93e8df49-28d1-499a-9fb1-36a270320194).html